Amphastar Pharmaceuticals, Inc. — Director's Dealing 2018

Nov 30, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2018-11-29

Reporting Person: PRINS RICHARD K (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-29	Common Stock	M	5000	$14.66	Acquired	40434	Direct
2018-11-29	Common Stock	S	5000	$20.50	Disposed	35434	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-29	Stock Option (right to buy)	$14.66	M	5000	Disposed	2018-12-20	Common Stock (5000)	Direct

Footnotes

F1: Shares subject to the option are fully vested and immediately exercisable.